Research Topics
| Susan E AndradeSummaryAffiliation: Meyers Primary Care Institute Country: USA Publications
| Collaborators
|
Detail Information
Publications
Validity of health plan and birth certificate data for pregnancy researchSusan E Andrade
Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester, MA, USA
Pharmacoepidemiol Drug Saf 22:7-15. 2013..To evaluate the validity of health plan and birth certificate data for pregnancy research...- Medication Exposure in Pregnancy Risk Evaluation ProgramSusan E Andrade
Meyers Primary Care Institute, 630 Plantation St, Worcester, MA 01605, USA
Matern Child Health J 16:1349-54. 2012..This partnership combines clinical and research expertise and data resources to enable the evaluation of outcomes associated with medication use during pregnancy... 
Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysisSusan E Andrade
Meyers Primary Care Institute Fallon Foundation and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA 01605, USA
J Clin Epidemiol 58:171-4. 2005....- Use of prescription medications with a potential for fetal harm among pregnant womenSusan E Andrade
Meyers Primary Care Institute University of Massachusetts Medical School, the Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 15:546-54. 2006..To estimate the prevalence of use of prescription drugs with a potential for fetal harm among pregnant women in the United States... - Use of antidepressant medications during pregnancy: a multisite studySusan E Andrade
Meyers Primary Care Institute, Worcester, MA 01605, USA
Am J Obstet Gynecol 198:194.e1-5. 2008..This study was undertaken to provide information on the prevalence of use of antidepressant drugs among pregnant women in the United States... 
Outpatient use of cardiovascular drugs during pregnancySusan E Andrade
Meyers Primary Care Institute University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 17:240-7. 2008..To provide information on the prevalence of use of cardiovascular drugs, some of which may have fetotoxic or teratogenic effects, in the outpatient setting among pregnant women in the United States...- Antidepressant medication use and risk of persistent pulmonary hypertension of the newbornSusan E Andrade
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 18:246-52. 2009.... - Prescription drug use in pregnancySusan E Andrade
Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA, USA
Am J Obstet Gynecol 191:398-407. 2004..The purpose of this study was to provide information on the prevalence of the use of prescription drugs among pregnant women in the United States... - Methods for evaluation of medication adherence and persistence using automated databasesSusan E Andrade
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, Fallon Community Health Plan, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 15:565-74; discussion 575-7. 2006..Our aim was to perform a systematic review of the methods currently being used to assess adherence and persistence in pharmacoepidemiological and pharmacoeconomic studies using automated databases... - Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancySusan E Andrade
Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester, MA, USA
Pharmacoepidemiol Drug Saf 20:1168-76. 2011..To evaluate the validity of health plan administrative and claims data to identify pre-gestational and gestational diabetes, obesity, and ultrasounds among pregnant women... - Antipsychotic medication use among children and risk of diabetes mellitusSusan E Andrade
Meyers Primary Care Institute, University of Massachusetts, Worcester, MA 01605, USA
Pediatrics 128:1135-41. 2011..To assess whether the risk of incident diabetes was increased with the use of second-generation antipsychotics (SGAs) in a large diverse cohort of children... - A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative dataSusan E Andrade
Meyers Primary Care Institute Reliant Medical Group, Fallon Community Health Plan, and University of Massachusetts Medical School, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 21:100-28. 2012..To perform a systematic review of the validity of algorithms for identifying cerebrovascular accidents (CVAs) or transient ischemic attacks (TIAs) using administrative and claims data... - The dynamics of chronic gout treatment: medication gaps and return to therapyLeslie R Harrold
Meyers Primary Care Institute, Worcester, Mass, USA
Am J Med 123:54-9. 2010..To identify gaps in therapy with urate-lowering drugs for the treatment of gout as well as factors associated with resuming therapy... - A systematic review of validated methods for identifying heart failure using administrative dataJane S Saczynski
Division of Geriatric Medicine and Meyers Primary Care Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 21:129-40. 2012..To identify and describe the validity of algorithms used to detect heart failure (HF) using administrative and claims data sources... - Comparison of drug adherence rates among patients with seven different medical conditionsBecky A Briesacher
Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, Massachusetts Meyers Primary Care Institute, Worcester, MA 01605, USA
Pharmacotherapy 28:437-43. 2008..To compare drug adherence rates among patients with gout, hypercholesterolemia, hypertension, hypothyroidism, osteoporosis, seizure disorders, and type 2 diabetes mellitus by using a standardized approach... - Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspectiveLeslie R Harrold
Meyers Primary Care Institute, University of Massachusetts Medical School and Fallon Foundation, Worcester, MA 01655, USA
J Rheumatol 32:1076-80. 2005..To estimate the incidence of Churg-Strauss syndrome (CSS) among a large population of asthma drug users... - Early detection of adverse drug events within population-based health networks: application of sequential testing methodsJeffrey S Brown
Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
Pharmacoepidemiol Drug Saf 16:1275-84. 2007.... - Asthma drug use and the development of Churg-Strauss syndrome (CSS)Leslie R Harrold
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic and Fallon Community Health Plan, Worcester, MA 01655, USA
Pharmacoepidemiol Drug Saf 16:620-6. 2007..Using pooled data from two nested case-control studies, we examined the association between asthma drug use and the development of CSS... - Validity of gout diagnoses in administrative dataLeslie R Harrold
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, Massachusetts 01655, USA
Arthritis Rheum 57:103-8. 2007..To determine the utility of using administrative data for epidemiologic studies of gout by examining the validity of gout diagnoses in claims data... - Validation of an algorithm to estimate gestational age in electronic health plan databasesQian Li
Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
Pharmacoepidemiol Drug Saf 22:524-32. 2013..To validate an algorithm that uses delivery date and diagnosis codes to define gestational age at birth in electronic health plan databases... - Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveriesSengwee Toh
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
Arch Womens Ment Health 16:149-57. 2013..Studies are needed to examine the comparative safety and effectiveness of these medications relative to other therapeutic options in pregnancy... - Adherence with urate-lowering therapies for the treatment of goutLeslie R Harrold
Department of Medicine, The Meyers Primary Care Institute, Worcester, MA 01605, USA
Arthritis Res Ther 11:R46. 2009..Adherence to urate-lowering drugs (ULDs) has not been well evaluated among those with gout. Our aim was to assess the level and determinants of non-adherence with ULDs prescribed for gout... - Low frequency of treatment of osteoporosis among postmenopausal women following a fractureSusan E Andrade
Meyers Primary Care Institute-Fallon Healthcare System and University of Massachusetts Medical School, Worcester, MA 01605, USA
Arch Intern Med 163:2052-7. 2003..Interventions to improve the detection and treatment of osteoporosis in high-risk patients need to be developed... - Adherence and occurrence of fractures after switching to once-monthly oral bisphophonatesBecky A Briesacher
Meyers Primary Care Institute, Fallon Clinic and the Fallon Community Health Plan Worcester, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
Pharmacoepidemiol Drug Saf 19:1233-40. 2010..The study aim is to test whether switching from once-weekly BPs to once-monthly BPs improves adherence and fracture risk... - Bone density consequences of initiation and compliance with therapy for osteoporosisRobert A Yood
Fallon Clinic and Meyers Primary Care Institute, Worcester, Massachusetts 01605, USA
Arthritis Care Res (Hoboken) 62:1440-5. 2010..We sought to determine the bone density consequences of the decision to initiate and comply with therapy for OP... - Adoption of once-monthly oral bisphosphonates and the impact on adherenceBecky A Briesacher
University of Massachusetts Medical School, Meyers Primary Care Institute, and Fallon Clinic, Worcester, MA 01605, USA
Am J Med 123:275-80. 2010..The extent of the adoption of once-monthly bisphosphonates into general clinical practice is not known, nor is it known if the novel formulation improves adherence... - Administrative data used to identify patients with irritable bowel syndromeSarah L Goff
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation and Fallon Community Health Plan, 630 Plantation Street, Worcester, MA 01605, USA
J Clin Epidemiol 61:617-21. 2008..To assess the usefulness of health plan administrative data for identifying patients with irritable bowel syndrome (IBS)... - Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefsRobert A Yood
Fallon Clinic, Worcester, MA 01605, USA
J Gen Intern Med 23:1815-21. 2008..There are effective treatments to prevent osteoporotic fractures, but these treatments are underutilized... - Challenges of estimating health service utilization for osteoarthritis patients on a population levelLeslie R Harrold
Meyers Primary Care Institute, Fallon Healthcare System and University of Massachusetts Medical School, Worcester 01605, USA
J Rheumatol 29:1931-6. 2002.... - Medication adherence and use of generic drug therapiesBecky A Briesacher
Division of Geriatric Medicine, University of Massachusetts, Worcester, MA 01605, USA
Am J Manag Care 15:450-6. 2009..To assess whether lower copayments charged for generic drugs explain the improved drug adherence associated with use of generics... - Consequences of poor compliance with bisphosphonatesBecky A Briesacher
University of Massachusetts Medical School, Division of Geriatric Medicine, Biotech Four, Worcester, MA 01605, USA
Bone 41:882-7. 2007..This study was undertaken to assess rates of osteoporotic fractures and health care utilization as a function of bisphosphonate compliance in usual clinical practice... - Increased use of second-generation macrolide antibiotics for children in nine health plans in the United StatesChristopher J Stille
HMO Research Network Center for Education and Research on Therapeutics, University of Massachusetts Medical School, Worcester, MA 01655, USA
Pediatrics 114:1206-11. 2004.... - Identification of patients with Churg-Strauss syndrome (CSS) using automated dataLeslie R Harrold
Meyers Primary Care Institute, The University of Massachusetts Medical School and the Fallon Healthcare System, Worcester, MA 01655, USA
Pharmacoepidemiol Drug Saf 13:661-7. 2004..Our aim was to identify individuals with Churg-Strauss syndrome (CSS) among asthma drug users, based on patterns of diagnostic and procedural codes (termed 'algorithms') contained in automated claims data... - Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative studyKathleen M Mazor
Meyers Primary Care Institute, Worcester, Massachusetts, USA
Drugs Aging 27:999-1008. 2010..Osteoporosis is a significant health problem, especially for older women. Prescription osteoporosis medication can reduce fractures, but many women do not accept treatment or discontinue treatment before benefits are achieved... - Hypertension management: the care gap between clinical guidelines and clinical practiceSusan E Andrade
Meyers Primary Care Institute, Fallon Foundation, and University of Massachusetts Medical School, Worcester, Mass 01605, USA
Am J Manag Care 10:481-6. 2004..CONCLUSION: Efforts are required to reduce "therapeutic inertia," particularly in patients with modestly elevated systolic blood pressure levels... - Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization studySusan E Andrade
Meyers Primary Care Institute-Fallon Healthcare System and University of Massachusetts Medical School, Worcester, MA 01605, USA
J Clin Epidemiol 55:310-3. 2002..This study, using data from a large number of health plans located in different geographical regions, underscores the importance of evaluating the accuracy of the diagnoses from automated health plan databases... - Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?Susan E Andrade
Meyers Primary Care Institute Fallon Healthcare System, Worcester, Massachusetts 01605, USA
J Am Geriatr Soc 50:178-81. 2002..The vast majority of older people choosing less-comprehensive drug benefit plans appeared to make appropriate choices of plans based upon past utilization of prescription and other medical services... - Communicating safety information to physicians: an examination of dear doctor lettersKathleen M Mazor
Meyers Primary Care Institute, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 14:869-75. 2005..This study examined whether content, organization, and formatting of dear doctor letters (DDLs) influences physicians' responses to the letters... - Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic controlCynthia J Willey
Meyers Primary Care Institute, 630 Plantation Street, Worcester, MA 01605, USA
Am J Manag Care 12:435-40. 2006..The vast majority of patients treated with multiple oral antidiabetic agents had suboptimal glycemic control, suggesting a need for intensified efforts to treat this particular group of patients to recommended goal levels... - Medication adherence of patients with selected rheumatic conditions: a systematic review of the literatureLeslie R Harrold
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, MA, USA
Semin Arthritis Rheum 38:396-402. 2009..Our aim was to perform a systematic review of the literature examining adherence with treatments for inflammatory rheumatic conditions to assess the magnitude of the problem in this patient population... - Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockersMarsha A Raebel
Kaiser Permanente of Colorado Clinical Research Unit and School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80237 8066, USA
Pharmacoepidemiol Drug Saf 16:55-64. 2007..The purpose of this retrospective cohort study was to assess creatinine and potassium monitoring and characteristics associated with monitoring among patients dispensed ACEi or ARB... - Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensingsLisa J Herrinton
Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
Inflamm Bowel Dis 13:451-61. 2007..There are few contemporary estimates of prevalence rates for inflammatory bowel disease (IBD) in diverse North American communities... - Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patientsSusan M Abughosh
Pharmacoepidemiology and Pharmacoeconomics Program, University of Rhode Island, Kingston, Rhode Island 02881, USA
J Manag Care Pharm 10:404-11. 2004..To determine the effects of lipid-lowering agent (LLA) class and drug plan design option on persistence with LLAs among elderly patients enrolled in a managed care plan... - Risk factors for statin-associated rhabdomyolysisStephanie Schech
Center for Health Care Policy and Evaluation, Eden Prairie, MN 55344, USA
Pharmacoepidemiol Drug Saf 16:352-8. 2007..To identify and characterize risk factors for rhabdomyolysis in patients prescribed statin monotherapy or statin plus fibrate therapy... - Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative dataMarsha A Raebel
HMO Research Network, Center for Education and Research on Therapeutics CERTs, Denver, CO, USA
Pharmacoepidemiol Drug Saf 14:829-36. 2005..Our aim was to evaluate the 270-day gestational age and delivery date assumptions used in an administrative dataset study assessing prenatal drug exposure compared to information contained in a birth registry... - Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001Steven R Simon
HMO Research Network, Center for Education and Research on Therapeutics, Harvard Pilgrim Health Care and Harvard Medical School, Boston, Massachusetts 02215, USA
J Am Geriatr Soc 53:227-32. 2005..To determine rates of potentially inappropriate medication use in elderly persons in managed care plans in the United States in 2000-2001... - Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugsDavid J Graham
Office of of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, USA
JAMA 292:2585-90. 2004..Lipid-lowering agents are widely prescribed in the United States. Reliable estimates of rhabdomyolysis risk with various lipid-lowering agents are not available... - FDA drug prescribing warnings: is the black box half empty or half full?Anita K Wagner
Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
Pharmacoepidemiol Drug Saf 15:369-86. 2006..The purpose of the present study was to assess the frequency of use of BBW medications in ambulatory care and prescribing compliance with BBW recommendations... - Chronic disease score as a predictor of hospitalizationKathleen G Putnam
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
Epidemiology 13:340-6. 2002..9 to 10.2. CONCLUSIONS: The Chronic Disease Score predicts hospitalization and therefore may be a useful indicator of baseline comorbidity for control of confounding... - Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation)Stephen J Kogut
Program in Pharmacoepidemiology and Pharmacoeconomics, University of Rhode Island, Kingston, RI, USA
Pharmacoepidemiol Drug Saf 13:591-8. 2004..To determine if nonadherence with antidiabetic drug therapy is predictive of subsequent antidiabetic drug therapy intensification... - Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOsMarsha A Raebel
Kaiser Permanente Colorado Clinical Research Unit, P O Box 378066, Denver, CO 80237 8066, USA
J Manag Care Pharm 12:656-64. 2006..Amiodarone can cause liver and thyroid toxicity, but little is known about compliance with laboratory tests to evaluate liver and thyroid function among ambulatory patients who are dispensed amiodarone... - Liver function testing in patients on HMG-CoA reductase inhibitorsSusan E Andrade
Department of Applied Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA
Pharmacoepidemiol Drug Saf 12:307-13. 2003..We sought to determine the frequency and patterns of LFT screening in patients receiving HMG-CoA reductase inhibitors... - Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancyRobert L Davis
Center for Health Studies, Group Health Cooperative, Seattle, WA, USA
Pharmacoepidemiol Drug Saf 16:1086-94. 2007..To evaluate risks for perinatal complications and congenital defects among infants exposed in utero to antidepressants... - Laboratory monitoring of drugs at initiation of therapy in ambulatory careMarsha A Raebel
Kaiser Permanente of Colorado Clinical Research Unit, Denver, CO 80237 8066, USA
J Gen Intern Med 20:1120-6. 2005..The objective of this study was to describe laboratory monitoring among ambulatory patients dispensed medications for which laboratory testing is recommended at therapy initiation... - Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrolleesSteven R Simon
HMO Research Network Center for Education and Research in Therapeutics and Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
J Am Geriatr Soc 53:2165-9. 2005..To identify correlates of laboratory monitoring errors in elderly health maintenance organization (HMO) members at the initiation of therapy with cardiovascular medications... - Hormone therapy initiation after the Women's Health InitiativeKatherine M Newton
Group Health Center for Health Studies, Seattle, WA 98101, USA
Menopause 15:487-93. 2008..To describe hormone therapy (HT) initiation after the 2002 publication of the Women's Health Initiative... - Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much?Douglas W Roblin
Research Department, Kaiser Permanente, Atlanta, Georgia 30305, and the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA
Med Care 43:951-9. 2005..For patients with a chronic disease, increased cost-sharing for medications may lead to unintended consequences, including reduced use of medications essential for control of their disease...